ursodeoxycholic acid has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YH; Im, EO; Jin, Y; Kim, KW; Kim, ND; Lee, WH; Suh, H; Yoo, YH | 1 |
| Callander, NS; Clement, DJ; Essell, JH; Halvorson, RD; Harman, GS; Snyder, MJ; Thompson, JM | 1 |
1 trial(s) available for ursodeoxycholic acid and Leukemia
| Article | Year |
|---|---|
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Male; Middle Aged; Transplantation, Homologous; Ursodeoxycholic Acid | 1992 |
1 other study(ies) available for ursodeoxycholic acid and Leukemia
| Article | Year |
|---|---|
Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Survival; Chenodeoxycholic Acid; Cholagogues and Choleretics; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Down-Regulation; Gastrointestinal Agents; Humans; Jurkat Cells; Leukemia; Phosphorylation; Poly(ADP-ribose) Polymerases; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2001 |